Back
Neurocrine Biosciences Vs. Globus Medical Industry Stock Comparison
Buy
61
NBIX
Neurocrine Biosciences
Last Price:
140.53
Seasonality Move:
7.49%
Buy
57
GMED
Globus Medical
Last Price:
66.49
Seasonality Move:
1.71%
Buy
61
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $141.65. The Score for NBIX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Globus Medical (GMED)
is a Buy
Is Globus Medical a Buy, Sell or Hold?
- The current Globus Medical [GMED] share price is $66.26. The Score for GMED is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- GMED is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $141.65
The current trend is moderately bullish and NBIX is experiencing slight buying pressure.
GMED Stock Price Chart
What is Globus Medical's stock price today?
-
The Globus Medical share price today is $66.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMED is experiencing slight buying pressure.
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 55.55 | Buy |
| Chaikin Money Flow: | 73257 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.01 - 141.79) | Buy |
| Bollinger Bands (100): | (133.2 - 140.8) | Buy |
GMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.61 | Buy |
| Relative Strength Index (14 RSI): | 75.82 | Buy |
| Chaikin Money Flow: | 263707 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.23 - 62.01) | Buy |
| Bollinger Bands (100): | (50.52 - 57.62) | Buy |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 139.84 | Buy |
| 20-day SMA: | 139.78 | Buy |
| 50-day SMA: | 138.64 | Buy |
| 200-day SMA: | 124.62 | Buy |
| 8-day EMA: | 140.7 | Buy |
| 20-day EMA: | 139.57 | Buy |
| 50-day EMA: | 138.01 | Buy |
| 200-day EMA: | 126.86 | Buy |
GMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.35 | Buy |
| 20-day SMA: | 56.75 | Buy |
| 50-day SMA: | 54.1 | Buy |
| 200-day SMA: | 52.25 | Buy |
| 8-day EMA: | 63.13 | Buy |
| 20-day EMA: | 58.94 | Buy |
| 50-day EMA: | 55.6 | Buy |
| 200-day EMA: | 54.16 | Buy |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.04 per share, an increase this year of $1.88 per share, and an increase next year of $1.37 per share.
Globus Medical Earnings Growth & GMED Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.15 per share, an increase this year of $0.51 per share, and an increase next year of $0.50 per share.
Neurocrine Biosciences Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Globus Medical Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||